294 related articles for article (PubMed ID: 16242744)
21. Testicular persistence of Parvovirus B19: evidence for preferential infection of germ cell tumors.
Ergunay K; Tezel GG; Dogan AI; Ozen H; Sirin G; Ozbay M; Karabulut E; Ustacelebi S
Pathol Res Pract; 2008; 204(9):649-53. PubMed ID: 18539403
[TBL] [Abstract][Full Text] [Related]
22. Detection of rat parvovirus type 1 and rat minute virus type 1 by polymerase chain reaction.
Wan CH; Bauer BA; Pintel DJ; Riley LK
Lab Anim; 2006 Jan; 40(1):63-9. PubMed ID: 16460590
[TBL] [Abstract][Full Text] [Related]
23. Humoral immunity and protection of mice challenged with homotypic or heterotypic parvovirus.
Hansen GM; Paturzo FX; Smith AL
Lab Anim Sci; 1999 Aug; 49(4):380-4. PubMed ID: 10480642
[TBL] [Abstract][Full Text] [Related]
24. Construction and sequencing of an infectious clone of the human parvovirus B19.
Zhi N; Zádori Z; Brown KE; Tijssen P
Virology; 2004 Jan; 318(1):142-52. PubMed ID: 14972543
[TBL] [Abstract][Full Text] [Related]
25. Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.
Bönsch C; Kempf C; Ros C
J Virol; 2008 Dec; 82(23):11784-91. PubMed ID: 18815302
[TBL] [Abstract][Full Text] [Related]
26. Variants of B19.
Brown KE
Dev Biol (Basel); 2004; 118():71-7. PubMed ID: 15645675
[TBL] [Abstract][Full Text] [Related]
27. Real-time PCR protocol for the detection of porcine parvovirus in field samples.
Wilhelm S; Zimmermann P; Selbitz HJ; Truyen U
J Virol Methods; 2006 Jun; 134(1-2):257-60. PubMed ID: 16472875
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of parvovirus B19 by liquid heating incorporated in the manufacturing process of human intravenous immunoglobulin preparations.
Yunoki M; Urayama T; Tsujikawa M; Sasaki Y; Abe S; Takechi K; Ikuta K
Br J Haematol; 2005 Feb; 128(3):401-4. PubMed ID: 15667545
[TBL] [Abstract][Full Text] [Related]
29. Secondary structure of DNA released from purified capsids of human parvovirus B19 under moderate denaturing conditions.
Matz B; Kupfer B; Kallies R; Külshammer M; Flötenmeyer M; Kreil TR; Eis-Hübinger AM
J Gen Virol; 2019 May; 100(5):812-827. PubMed ID: 30924765
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
Kleinman SH; Glynn SA; Lee TH; Tobler L; Montalvo L; Todd D; Kiss JE; Shyamala V; Busch MP;
Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600
[TBL] [Abstract][Full Text] [Related]
31. Multiplex polymerase chain reaction assay for the detection of minute virus of mice and mouse parvovirus infections in laboratory mice.
Wang KW; Chueh LL; Wang MH; Huang YT; Fang BH; Chang CY; Fang MC; Chou JY; Hsieh SC; Wan CH
Lab Anim; 2013 Apr; 47(2):116-21. PubMed ID: 23492514
[TBL] [Abstract][Full Text] [Related]
32. Antiangiogenic Vascular Endothelial Growth Factor-Blocking Peptides Displayed on the Capsid of an Infectious Oncolytic Parvovirus: Assembly and Immune Interactions.
Grueso E; Sánchez-Martínez C; Calvo-López T; de Miguel FJ; Blanco-Menéndez N; Fernandez-Estevez M; Elizalde M; Sanchez J; Kourani O; Martin D; Tato A; Guerra M; Andrés G; Almendral JM
J Virol; 2019 Oct; 93(19):. PubMed ID: 31315994
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens.
Bonvicini F; Manaresi E; Gallinella G; Gentilomi GA; Musiani M; Zerbini M
BJOG; 2009 May; 116(6):813-7. PubMed ID: 19432570
[TBL] [Abstract][Full Text] [Related]
34. The structure of human parvovirus B19 at 8 A resolution.
Agbandje M; Kajigaya S; McKenna R; Young NS; Rossmann MG
Virology; 1994 Aug; 203(1):106-15. PubMed ID: 8030266
[TBL] [Abstract][Full Text] [Related]
35. Human parvovirus B19 VP2 empty capsids bind to human villous trophoblast cells in vitro via the globoside receptor.
Wegner CC; Jordan JA
Infect Dis Obstet Gynecol; 2004 Jun; 12(2):69-78. PubMed ID: 15739820
[TBL] [Abstract][Full Text] [Related]
36. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
[TBL] [Abstract][Full Text] [Related]
37. Variability of parvovirus B19 to inactivation by liquid heating in plasma products.
Hattori S; Yunoki M; Tsujikawa M; Urayama T; Tachibana Y; Yamamoto I; Yamamoto S; Ikuta K
Vox Sang; 2007 Feb; 92(2):121-4. PubMed ID: 17298573
[TBL] [Abstract][Full Text] [Related]
38. The Mammalian Cell Cycle Regulates Parvovirus Nuclear Capsid Assembly.
Gil-Ranedo J; Hernando E; Riolobos L; Domínguez C; Kann M; Almendral JM
PLoS Pathog; 2015 Jun; 11(6):e1004920. PubMed ID: 26067441
[TBL] [Abstract][Full Text] [Related]
39. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
[TBL] [Abstract][Full Text] [Related]
40. Human erythrovirus B19 and blood transfusion - an update.
Parsyan A; Candotti D
Transfus Med; 2007 Aug; 17(4):263-78. PubMed ID: 17680952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
